Dr. Reddy’s joins forces with Gilead Sciences to launch HIV drug Lenacapavir in India and 120 countries
In a historic development for HIV treatment worldwide, Dr. Reddy's Laboratories has announced a new partnership with Gilead Sciences to manufacture and commercialize a revolutionary ... Read More
Dr. Reddy’s Laboratories takes $620m gamble in Switzerland: Could this bold move dominate Europe?
Dr. Reddy’s Laboratories, the Indian pharmaceutical giant, has solidified its European ambitions with a monumental $620 million investment in its Switzerland-based subsidiary, Dr. Reddy’s Laboratories ... Read More
Dr. Reddy’s Laboratories secures key European endorsement for Rituximab biosimilar
In a significant development for the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd. has received a positive opinion from the European Medicines Agency’s (EMA) Committee for ... Read More
Haleon to sell non-US nicotine replacement therapy portfolio to Dr. Reddy’s Laboratories
Haleon plc, a prominent player in the global healthcare market, has reached an agreement to sell its nicotine replacement therapy (NRT) business outside of the ... Read More
Dr. Reddy’s Laboratories launches DailyBloom IBS : India’s first integrated care plan for irritable bowel syndrome
Dr. Reddy's Laboratories Ltd., a globally recognized pharmaceutical company, has unveiled DailyBloom IBS, marking a significant advancement in the management of Irritable Bowel Syndrome (IBS) ... Read More
Dr. Reddy’s Laboratories launches migraine management wearable Nerivio in Germany
In an exciting development for migraine sufferers, Dr. Reddy’s Laboratories Ltd., a leader in the global pharmaceutical industry, has announced the launch of its groundbreaking, ... Read More
Dr. Reddy’s Laboratories launches Versavo in UK, marking a milestone in cancer treatment
Dr. Reddy’s Laboratories Ltd., a leading global pharmaceutical company, has made significant strides in cancer treatment with the introduction of Versavo (bevacizumab) in the United ... Read More
Dr. Reddy’s Laboratories expands wellness portfolio with MenoLabs acquisition
In a significant move within the healthcare industry, Dr. Reddy's Laboratories Ltd. has announced the acquisition of the MenoLabs business, a prominent player in women's ... Read More
Coya Therapeutics partners with Dr. Reddy’s for neurodegenerative disease therapy development
Coya Therapeutics, Inc. (NASDAQ: COYA), a clinical-stage biotechnology company, has entered into a worldwide agreement with Dr. Reddy’s Laboratories Limited, a global pharmaceutical leader, marking ... Read More
Dr. Reddy’s Laboratories introduces FDA-approved Nerivio for migraine management in India
Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company, has announced the rollout of Nerivio in India. This state-of-the-art, United States Food and Drug Administration (USFDA) ... Read More